Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
WT1 expression
i
Other names:
WT1, WT1 Transcription Factor, Wilms Tumor Protein, Wilms Tumor 1, WT33, NPHS4, WIT-2, AWT1, WAGR, GUD
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7490
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
›
Associations
(2)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Study of 3D189 in Patients With Hematologic Malignancies (NCT05320809)
Phase 1
3D Medicines
3D Medicines
Active, not recruiting
Phase 1
3D Medicines
Active, not recruiting
Last update posted :
10/25/2023
Initiation :
08/01/2022
Primary completion :
05/01/2024
Completion :
12/01/2024
WT1
|
WT1 expression • WT1 positive
|
Zeltherva (galinpepimut-S)
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers (NCT05360680)
Phase 1
Cue Biopharma
Cue Biopharma
Recruiting
Phase 1
Cue Biopharma
Recruiting
Last update posted :
09/27/2023
Initiation :
06/14/2022
Primary completion :
12/01/2024
Completion :
12/01/2026
WT1 • CTLA4
|
WT1 expression • WT1 positive
|
CUE-102
A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer (NCT02737787)
Phase 1
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Completed
Phase 1
Memorial Sloan Kettering Cancer Center
Completed
Last update posted :
04/07/2023
Initiation :
04/01/2016
Primary completion :
04/06/2023
Completion :
04/06/2023
WT1 • MUC16 • CTAG1B
|
WT1 expression • CTAG1B expression • WT1 positive
|
Opdivo (nivolumab) • Zeltherva (galinpepimut-S)
WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation (NCT01827137)
Phase N/A
Sellas Life Sciences Group
Sellas Life Sciences Group
Unknown status
Phase N/A
Sellas Life Sciences Group
Unknown status
Last update posted :
01/10/2020
Initiation :
04/01/2013
Primary completion :
06/01/2018
Completion :
08/01/2020
IFNG • WT1 • CD4
|
WT1 expression • WT1 positive
|
lenalidomide • bortezomib • Zeltherva (galinpepimut-S) • Leukine (sargramostim)
Reduced Intensity Transplant Using Extracorporeal Photopheresis (NCT00179790)
Phase 1/2
Ann & Robert H Lurie Children's Hospital of Chicago
Ann & Robert H Lurie Children's Hospita...
Completed
Phase 1/2
Ann & Robert H Lurie Children's Hospital of Chi...
Completed
Last update posted :
03/06/2017
Initiation :
07/01/2005
Primary completion :
06/01/2010
Completion :
01/01/2015
IFNG • TNFA • WT1 • IL2RA • CD4 • IL10 • IL4 • ISG20
|
WT1 expression • WT1 positive
|
fludarabine IV • busulfan
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login